Skip to main content

Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • On Demand
  • Prologue: Using Potency Readouts to Establish Critical Quality Attributes and Inform Vector Characterization Priorities
    Prologue Speaker: Hangtian Song, PhD – Bristol-Myers Squibb Company
    Manufacturing & Analytical Characterization
  • Prologue:  Applying Machine Learning to the Laboratory: How AI Can Help Us Innovate
    Prologue Speaker: Vibha Jawa, PhD FAAPS (she/her/hers) – Bristol Myers Squibb
    Bioanalytics
  • Prologue:  Challenges in Bioanalysis
    Prologue Speaker: Catherine Vrentas, PhD, MBA, MPH (she/her/hers) – Booz Allen Hamilton
    Bioanalytics
  • Prologue:  Regulatory Implications: From Immunogenicity to Diagnostics
    Prologue Speaker: Mohsen Rajabi, Ph.D. – US Food and Drug Administration
    Bioanalytics
  • Prologue:  Understanding HRMS in Regulated Bioanalysis, with Applications for ADCs
    Prologue Speaker: William R. Mylott, Jr., BS Chemistry – Thermo Fisher Scientific
    Bioanalytics
  • Prologue: Big Data Approaches to Understanding Particle Properties
    Prologue Speaker: Mike Tobyn, PhD (he/him/his) – Bristol Myers Squibb
    Manufacturing & Analytical Characterization
  • Prologue: Biomarker Strategies in Therapeutics Development for Rare Diseases
    Prologue Speaker: Yow-Ming Wang, PhD – US Food and Drug Administration
    Preclinical, Clinical and Translational Sciences
  • Prologue: Biomarkers as Linkers Between Preclinical, Clinical, and Patient Outcome
    Prologue Speaker: Matt D. Harwood, MSc, PhD – Certara UK (Simcyp Division)
    Preclinical, Clinical and Translational Sciences
  • Prologue: Can We Deliver Macro Peptides Orally?
    Prologue Speaker: Jenna Walker, PhD – Eli Lilly
    Formulation and Delivery
  • Prologue: Employing Machine Learning to Image, Quantify, and Predict Pharmacokinetics to Support Drug Development
    Prologue Speaker: Conor Evans, PhD – Massachusetts General Hospital / Harvard Medical School
    Preclinical, Clinical and Translational Sciences
  • Prologue: Flexible Manufacturing at Merck
    Prologue Speaker: Anna Jenks (she/her/hers) – Merck & Co., Inc. - Rahway NJ
    Manufacturing & Analytical Characterization
  • Prologue: High Dose Subcutaneous Delivery of Protein Therapeutics
    Prologue Speaker: Erica Schlesinger, PhD (she/her/hers) – Seran Biosciences, LLC
    Formulation and Delivery
  • Prologue: Integrated in vitro-in silico Approach in Clinical Drug Development
    Prologue Speaker: Siddhi S. Hate, PhD – Eli Lilly and Company
    Formulation and Delivery
  • Prologue: LNP's: Formulations that Pushed Back COVID-19
    Prologue Speaker: Rajiv Nayar, PhD – HTD Biosystems Inc.
    Manufacturing & Analytical Characterization
  • Prologue: Mechanistic Models in Manufacturing
    Prologue Speaker: Indrajit Jagtap (he/him/his) – Intelimek LLC
    Manufacturing & Analytical Characterization
  • Prologue: Methods to Assess the Targeted Brain Drug Delivery in Preclinical Settings
    Prologue Speaker: Irena Loryan, MD, PhD (she/her/hers) – Uppsala University
    Discovery and Basic Research
  • Prologue: Prospects and Challenges of Cell Selective Liposome for the Treatment of Auto-Immune Diseases
    Prologue Speaker: Md Nurunnabi, PhD – University of Mississippi
    Discovery and Basic Research
  • Prologue: Regulatory Considerations for Continuous Manufacturing
    Prologue Speaker: Scott M. Krull, PhD (he/him/his) – US Food and Drug Administration
    Manufacturing & Analytical Characterization
  • Prologue: Regulatory Implications: from Immunogenicity to Diagnostics
    Prologue Speaker: Weifeng Xu, PhD – Merck & Co.
    Bioanalytics
  • Prologue: The Effect of Excipients on the Colloidal Stability of Monoclonal Antibodies
    Prologue Speaker: Stephen W. Hoag, PhD – University of Maryland Baltimore
    Formulation and Delivery
  • Prologue: Transforming Drug Development: Advanced Modeling and Virtual Data for Enhanced Trials
    Prologue Speaker: Vibha Jawa, PhD FAAPS (she/her/hers) – Bristol Myers Squibb
    Preclinical, Clinical and Translational Sciences
  • 12:00 PM – 1:00 PM MT
    Prologue: How Artificial Intelligence will Redefine the Roles of Scientific and Medical Writers
    Prologue Speaker: David Hauss, PhD, RPh – Hauss Associates LLC
    Discovery and Basic Research